Letter: comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for noninvasive diagnosis of advanced fibrosis in biopsy‐proven NAFLD
Letter: comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for noninvasive diagnosis of advanced fibrosis in biopsy‐proven NAFLD
复制标题
信件:磁共振弹性成像与八种临床预测规则对活检证实的 NAFLD 晚期纤维化无创诊断的诊断准确性比较
DOI:
10.1111/apt.13871
复制
发表时间:
2017
影响因子:
7.6
通讯作者:
M. Shao
中科院分区:
文献类型:
--
作者:
H. Shi;L. Liu;M. Shao
SIRS, We read the article by Cui et al. with interest. As we know, the prevalence rate of nonalcoholic fatty liver disease (NAFLD) has increased year by year recently. NAFLD ranges from benign hepatic fat accumulation to nonalcoholic steatohepatitis, which is a progressive form of disease that may lead to fibrosis, cirrhosis, and hepatocellular carcinoma. However, the identification of advanced fibrosis is complicated in clinical practice. In the prospective article, the authers propose a new indicator, two-dimensional magnetic resonance elastography (2D-MRE), which is an advanced magnetic resonance imaging modality utilising shear waves. The results have revealed that 2D-MRE had provided a significantly higher accuracy for diagnosis of advanced fibrosis in NAFLD patients compared to other clinical prediction rules. However, we still have some questions concerning this study. The aim of Jeffrey’s study was to find an indicator to differentiate advanced fibrosis from others. A wellaccepted definition of advanced fibrosis is F3–F4. In this article, 48, 26, 9, 13 and 6 patients suffered stage 0, 1, 2, 3 and 4 fibrosis, respectively. Thus, only 19 (18.6%) cases of the patients were advanced fibrosis (stage 3–4 fibrosis) (table 1). The proportion of positive cases was relatively low. Thus, we think that design of the sample size about this study has small flaws. Hajian-Tilaki provided a conceptual framework of sample size calculations in the studies of diagnostic test accuracy in various conditions and test outcomes. According to this article, we have calculated the sample size of the prospective study above and found it is not less than 100. In this research, the total sample size is only 102, and the proportion of the experimental samples only accounts for 18.6% of the total sample. Therefore, the result could be more convincing, if the sample size is larger. In addition, in developing countries, the cost-effectiveness of MRE is another aspect which needs to be addressed. Compared with MRE, transient elastography (Fibroscan, Echosens, Paris, France) is cheaper, faster and more convenient. Many studies have shown that Fibroscan has demonstrated very promising results for the diagnosis of liver fibrosis in NAFLD, 8 especially for longitudinal follow-up of patients with NAFLD. Thus, further studies are needed to compare MRE with elastography techniques. If Fibroscan has more advantages compared with MRE, it will greatly reduce the costs of inspection, and is more conducive for follow-up. In conclusion, 2D-MRE is promising, effective, and available radiographically to diagnose advanced fibrosis, but we think more data are required to prove the arguments. Further studies are needed to evaluate the advantages and disadvantages of 2D-MRE. Also, the comparation and combination of these technologies awaits further study.